Legislative victories fuel advocates for coverage of biomarker testing

CEO Barnaby Balmforth is featured in a MedCity News article highlighting recent legislative efforts to expand insurance coverage for comprehensive biomarker testing in the United States. 

He discusses how the company aims to make testing more affordable with its breakthrough technology and the driving force behind their mission—that all patients should have access to the genomic information needed to ensure the best possible cancer treatment.

Read on MedCity News